DBV Technologies
DBVT
$0.58
Share price
-1.25%
Change (1 day)
-70.08%
Change (1 year)
Categories
DBV Technologies (DBVT) - Total debt
Total debt on the balance sheet as of December 2023 : $6.55 M
According to DBV Technologies's latest financial reports the company's total debt is $6.55 M. A company’s total debt is the sum of all current and non-current debts.
DBV Technologies - Total debt on balance sheet (from 2021 to 2020)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $6.55 M | 57.83% |
| 2022-12-31 | $4.15 M | -65.36% |
| 2021-12-31 | $11.98 M | -40.84% |
| 2020-12-31 | $20.25 M | -34.74% |
| 2019-12-31 | $31.04 M | 518.9% |
| 2018-12-31 | $5.01 M | -24.12% |
| 2017-12-31 | $6.61 M | 24.76% |
| 2016-12-31 | $5.29 M | -12% |
| 2015-12-31 | $6.02 M | -3.95% |
| 2014-12-31 | $6.26 M | 119.9% |
| 2013-12-31 | $2.85 M | 33.52% |
| 2012-12-31 | $2.13 M | 55.12% |
| 2011-12-31 | $1.37 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Ionis Pharmaceuticals
IONS | $1.45 B | 22,081.29% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | N/A | N/A | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $1.30 B | 19,757.01% | 🇺🇸 USA |